RxDoctor Payments Data

Ollie Jones, MD

Gastroenterology · Flowood, MSNPI 1265725758

Payments from drug & device makers

$1,735in general payments, 2019–2025

Across 89 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$435
  • Boston Scientific$283
  • Bristol Myers Squibb$241
  • Takeda Pharmaceuticals U.S.A., Inc.$215
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$214
  • Nestle Healthcare Nutrition Inc.$57
  • plus $290 from 13 others

What the payments were for

  • Food & beverage$1,735100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,735 in reported general payments places this provider in the 25th percentile of 127 gastroenterology providers in Mississippi.

See all gastroenterology providers in Mississippi

Medicare billing

Part B allowed, 2024
$535,699
Medicare patients
584
Services billed
23,387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GattexTeduglutide12$534,781
LinzessLinaclotide40$45,149
ClenpiqSod Picosulf/Mag Ox/Citric Ac25$4,088
SutabSod Sulf/Pot Chloride/Mag Sulf23$3,717
Dicyclomine Hcl179$2,558
Pantoprazole Sodium362$1,944
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl116$1,820
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg54$1,395
Clarithromycin14$702
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl26$475
Sucralfate13$283
ConstuloseLactulose11$280
Lansoprazole13$234
Famotidine12$172
Omeprazole13$118

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Gattex$215$534,78112 claims
AbbVieLinzess$435$45,14940 claims
Braintree Laboratories, Inc.Sutab$34$3,71723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 127 gastroenterology providers in Mississippi.

Other gastroenterology in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →